The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
DNA Vaccines: Progress and Challenges
Abstract
In the years following the publication of the initial in vivo demonstration of the ability of plasmid DNA to generate protective immune responses, DNA vaccines have entered into a variety of human clinical trials for vaccines against various infectious diseases and for therapies against cancer, and are in development for therapies against autoimmune diseases and allergy. They also have become a widely used laboratory tool for a variety of applications ranging from proteomics to understanding Ag presentation and cross-priming. Despite their rapid and widespread development and the commonplace usage of the term “DNA vaccines,” however, the disappointing potency of the DNA vaccines in humans underscores the challenges encountered in the efforts to translate efficacy in preclinical models into clinical realities. This review will provide a brief background of DNA vaccines including the insights gained about the varied immunological mechanisms that play a role in their ability to generate immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318
Self-citationControl of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Racz, P., Tenner-Racz, K., Dalesandro, M., Scallon, B. J., et al. (1999) · Science · doi:10.1126/science.283.5403.857 · Cited by 2,187
Genetic immunization is a simple method for eliciting an immune response
Tang, D.-C., DeVit, M., & Johnston, S. A. (1992) · Nature · doi:10.1038/356152a0 · Cited by 1,498
Donnelly, J. J., Ulmer, J. B., Shiver, J. W., & Liu, M. A. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.617 · Cited by 987
Self-citationBarouch, D. H., Santra, S., Schmitz, J. E., Kuroda, M. J., Fu, T.-M., Wagner, W., Bilska, M., Craiu, A., Zheng, X. X., Krivulka, G. R., et al. (2000) · Science · doi:10.1126/science.290.5491.486 · Cited by 881
Srivastava, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064801 · Cited by 850
Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA Vaccine
Wang, R., Doolan, D. L., Le, T. P., Hedstrom, R. C., Coonan, K. M., Charoenvit, Y., Jones, T. R., Hobart, P., Margalith, M., Ng, J., et al. (1998) · Science · doi:10.1126/science.282.5388.476 · Cited by 833
Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo
Widera, G., Austin, M., Rabussay, D., Goldbeck, C., Barnett, S. W., Chen, M., Leung, L., Otten, G. R., Thudium, K., Selby, M. J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4635 · Cited by 606
Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B., & Rock, K. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4942 · Cited by 591
Sigal, L. J., Crotty, S., Andino, R., & Rock, K. L. (1999) · Nature · doi:10.1038/18038 · Cited by 578
Porgador, A., Irvine, K. R., Iwasaki, A., Barber, B. H., Restifo, N. P., & Germain, R. N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1075 · Cited by 560
McConkey, S. J., Reece, W. H. H., Moorthy, V. S., Webster, D., Dunachie, S., Butcher, G., Vuola, J. M., Blanchard, T. J., Gothard, P., Watkins, K., et al. (2003) · Nature Medicine · doi:10.1038/nm881 · Cited by 553
Gene vaccination with naked plasmid DNA: mechanism of CTL priming.
Corr, M., Lee, D. J., Carson, D. A., & Tighe, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1555 · Cited by 475
Therapeutic dendritic-cell vaccine for chronic HIV-1 infection
Lu, W., Arraes, L. C., Ferreira, W. T., & Andrieu, J.-M. (2004) · Nature Medicine · doi:10.1038/nm1147 · Cited by 448
Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
Calarota, S., Bratt, G., Nordlund, S., Hinkula, J., Leandersson, A.-C., Sandström, E., & Wahren, B. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09440-3 · Cited by 400
Self-citationDavis, H. L., Michel, M.-L., & Whalen, R. G. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.11.1847 · Cited by 399
Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice
Dupuis, M., Denis-Mize, K., Woo, C., Goldbeck, C., Selby, M. J., Chen, M., Otten, G. R., Ulmer, J. B., Donnelly, J. J., Ott, G., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2850 · Cited by 327
Self-citationWang, Z., Troilo, P. J., Wang, X., Griffiths, T. G., Pacchione, S. J., Barnum, A. B., Harper, L. B., Pauley, C. J., Niu, Z., Denisova, L., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302213 · Cited by 322
Cancer immunotherapy with mRNA‐transfected dendritic cells
Gilboa, E., & Vieweg, J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00139.x · Cited by 316
Fu, T.-M., Ulmer, J. B., Caulfield, M. J., Deck, R. R., Friedman, A., Wang, S., Liu, X., Donnelly, J. J., Liu, M. A., & Wigzell, H. (1997) · Molecular Medicine · doi:10.1007/bf03401683 · Cited by 296
Self-citationRodriguez, F., Zhang, J., & Whitton, J. L. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8497-8503.1997 · Cited by 265
Iwasaki, A., Torres, C. A., Ohashi, P. S., Robinson, H. L., & Barber, B. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.11 · Cited by 245
Biological features of genetic immunization
Barry, M. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00265-4 · Cited by 221
Mwau, M., Cebere, I., Sutton, J., Chikoti, P., Winstone, N., Wee, E. G.-T., Beattie, T., Chen, Y.-H., Dorrell, L., McShane, H., et al. (2004) · Journal of General Virology · doi:10.1099/vir.0.19701-0 · Cited by 207
Barouch, D. H., Craiu, A., Kuroda, M. J., Schmitz, J. E., Zheng, X. X., Santra, S., Frost, J. D., Krivulka, G. R., Lifton, M. A., Crabbs, C. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050417697 · Cited by 200
Spies, B., Hochrein, H., Vabulas, M., Huster, K., Busch, D. H., Schmitz, F., Heit, A., & Wagner, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5908 · Cited by 199
zur Megede, J., Chen, M.-C., Doe, B., Schaefer, M., Greer, C. E., Selby, M., Otten, G. R., & Barnett, S. W. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2628-2635.2000 · Cited by 188
Tanghe, A., D'Souza, S., Rosseels, V., Denis, O., Ottenhoff, T. H. M., Dalemans, W., Wheeler, C., & Huygen, K. (2001) · Infection and Immunity · doi:10.1128/iai.69.5.3041-3047.2001 · Cited by 184
Manam, S., Ledwith, B. J., Barnum, A. B., Troilo, P. J., Pauley, C. J., Harper, L. B., Griffiths II, T. G., Niu, Z., Denisova, L., Follmer, T. T., et al. (2000) · Intervirology · doi:10.1159/000053994 · Cited by 183
Denis-Mize, K. S., Dupuis, M., MacKichan, M. L., Singh, M., Doe, B., O'Hagan, D., Ulmer, J. B., Donnelly, J. J., McDonald, D. M., & Ott, G. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301347 · Cited by 167
Self-citationEnhancement of DNA vaccine potency using conventional aluminum adjuvants
Ulmer, J. B., DeWitt, C. M., Chastain, M. A., Friedman, A., Donnelly, J., McClements, W. L., Caulfield, M. J., Bohannon, K. E., Volkin, D. B., & Evans, R. K. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00151-6 · Cited by 145
Self-citationMicroparticles for the delivery of DNA vaccines
O’Hagan, D. T., Singh, M., & Ulmer, J. B. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00153.x · Cited by 138
Progress in DNA‐based heterologous prime‐boost immunization strategies for malaria
Moore, A., & Hill, A. V. S. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00138.x · Cited by 134
Heterologous Envelope Immunogens Contribute to AIDS Vaccine Protection in Rhesus Monkeys
Letvin, N. L., Huang, Y., Chakrabarti, B. K., Xu, L., Seaman, M. S., Beaudry, K. R., Korioth-Schmitz, B., Yu, F. H., Rohne, D., Martin, K. L., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7490-7497.2004 · Cited by 131
Stevenson, F. K., Ottensmeier, C. H. H., Johnson, P., Zhu, D., Buchan, S. L., McCann, K. J., Roddick, J. S., King, A. T., McNicholl, F. P., Savelyeva, N., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404896101 · Cited by 122
Paliard, X., Liu, Y., Wagner, R., Wolf, H. J., Baenziger, J., & Walker, C. M. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200309368 · Cited by 121
Moore, A., Kong, W., Chakrabarti, B. K., & Nabel, G. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.243-250.2002 · Cited by 120
Kim, T. W., Lee, J.-H., He, L., Boyd, D. A. K., Hardwick, J. M., Hung, C., & Wu, T.-C. (2005) · Cancer Research · doi:10.1158/0008-5472.309.65.1 · Cited by 98
Calarota, S. A., & Weiner, D. B. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00150.x · Cited by 93
DermaVir: A Novel Topical Vaccine for HIV/AIDS
Lisziewicz, J., Trocio, J. N., Whitman, L., Varga, G., Xu, J., Bakare, N., Erbacher, P., Fox, C. H., Woodward, R. A., Markham, P., et al. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23535.x · Cited by 92
Tryniszewska, E. A., Nacsa, J., Lewis, M. G., Silvera, P. M., Montefiori, D. C., Venzon, D. J., Hel, Z., Parks, R. W., Moniuszko, M., Tartaglia, J., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5347 · Cited by 91
Cherpelis, S., Shrivastava, I., Gettie, A., Jin, X., Ho, D. D., Barnett, S. W., & Stamatatos, L. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1547-1550.2001 · Cited by 89
Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles
Denis-Mize, K. S., Dupuis, M., Singh, M., Woo, C., Ugozzoli, M., O’Hagan, D. T., Donnelly, J., Ott, G. S., & McDonald, D. M. (2003) · Cellular Immunology · doi:10.1016/j.cellimm.2003.09.003 · Cited by 79
Self-citationTargeting plasmid‐encoded proteins to the antigen presentation pathways
Leifert, J. A., Rodriguez‐Carreno, M. P., Rodrı́guez, F., & Whitton, J. L. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0135.x · Cited by 76
Nakano, I., Maertens, G. G., Major, M. E., Vitvitski, L., Dubuisson, J., Fournillier, A., MARTYNOFF, G. D., TREPO, C. G., & Inchauspé, G. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.7101-7109.1997 · Cited by 67
Ljungberg, K., Rollman, E., Eriksson, L. E., Hinkula, J., & Wahrén, B. (2002) · Virology · doi:10.1006/viro.2002.1547 · Cited by 65
DNA mucosal HIV vaccine in humans
Lundholm, P., Leandersson, A.-C., Christensson, B., Bratt, G., Sandström, E., & Wahrén, B. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00396-3 · Cited by 46
The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep
Drew, D. R., Boyle, J. S., Lew, A. M., Lightowlers, M. W., Chaplin, P. J., & Strugnell, R. A. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00196-7 · Cited by 45
Luby, T. M., Cole, G. A., Baker, L., Kornher, J. S., Ramstedt, U., & Hedley, M. L. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.04.002 · Cited by 45
MacGregor, R. R., Boyer, J., Ugen, K. E., Tebas, P., HIGGINS, T., Baine, Y., Ciccarelli, R., Ginsberg, R. S., & WEINER, D. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.010 · Cited by 43
Sedegah, M., Charoenvit, Y., Aguiar, J. C., Sacci, J. B., Hedstrom, R. C., Kumar, S., Belmonte, A. D., Lanar, D., Tr, J., Abot, E. N., et al. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364125 · Cited by 37
Spetz, A., Smed‐Sörensen, A., Walther–Jallow, L., Wahrén, B., Andersson, J., Holmgren, L., & Hinkula, J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5771 · Cited by 37
B lymphocytes as antigen‐presenting cell‐based genetic vaccines
Zanetti, M., Castiglioni, P., Rizzi, M., Wheeler, M., & Gerloni, M. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00152.x · Cited by 36
Protein expression in vivo by injection of polynucleotides
Montgomery, D. L., Donnelly, J., Shiver, J. W., et al. (1994) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(94)90065-5 · Cited by 30
Self-citationRelative Potency of Cellular and Humoral Immune Responses Induced by DNA Vaccination
Otten, G. R., Doe, B., Schaefer, M. E., Chen, M., Selby, M., Goldbeck, C., Hong, M., Xu, F., & Ulmer, J. B. (2000) · Intervirology · doi:10.1159/000053990 · Cited by 27
Megede, J. Z., Otten, G. R., Doe, B., Liu, H., Leung, L., Ulmer, J. B., Donnelly, J., & Barnett, S. W. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6197-6207.2003 · Cited by 27
Self-citation
Cited by
Khlebtsov, N., & Dykman, L. (2011) · Chem. Soc. Rev. · doi:10.1039/c0cs00018c · Cited by 1,584
Optical properties and biomedical applications of plasmonic nanoparticles
Khlebtsov, N. G., & Dykman, L. A. (2010) · Journal of Quantitative Spectroscopy and Radiative Transfer · doi:10.1016/j.jqsrt.2009.07.012 · Cited by 679
Polymers for gene delivery across length scales
Putnam, D. (2006) · Nature Materials · doi:10.1038/nmat1645 · Cited by 572
New Vaccine Technologies to Combat Outbreak Situations
Rauch, S., Jasny, E., Schmidt, K. E., & Petsch, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01963 · Cited by 579
Nanoparticle Vaccines Against Infectious Diseases
Pati, R., Shevtsov, M., & Sonawane, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02224 · Cited by 514
Metadata
- Authors
- Donnelly, J. J., Wahren, B., & Liu, M. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-07
- Volume
- 175
- Issue
- 2
- Pages
- 633-639
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2114754387
- Cited by
- 448
- References
- 58
- FWCI
- 13.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.